DexCom
DXCM
DXCM
320 hedge funds and large institutions have $7.78B invested in DexCom in 2017 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 100 increasing their positions, 123 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
16.14% less ownership
Funds ownership: 442.4% → 426.27% (-16%)
19% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 123
96% less call options, than puts
Call options by funds: $24.1M | Put options by funds: $577M
Holders
320
Holding in Top 10
3
Calls
$24.1M
Puts
$577M
Top Buyers
| 1 | +$346M | |
| 2 | +$162M | |
| 3 | +$94.9M | |
| 4 |
JP Morgan Chase
New York
|
+$79.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$69.8M |
Top Sellers
| 1 | -$175M | |
| 2 | -$97.2M | |
| 3 | -$66.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$61.2M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$45M |